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Background: We aimed to investigate the mortality and causes of deaths of inhabitants with renal dysfunction
induced by cadmium (Cd) exposure caused by heavy environmental contamination.
Methods: We conducted a 26-year follow-up survey targeting 7529 inhabitants of the Cd-polluted Jinzu River basin
and 2149 controls from non-polluted areas who participated in urinary examinations for proteinuria and glucosuria
conducted in 1979 to 1984. When the residents were divided into 4 groups, no finding group, glucosuria group,
proteinuria group, glucoproteinuria group, mortality risk ratios for all and specific causes of these groups in the
polluted area were compared with that of controls without glucosuria and/or proteinuria after adjustments for age
at baseline, smoking status, and history of hypertension using Cox’s proportional hazard model.
Results: The mortality risk ratios for all causes of proteinuria and glucoproteinuria in men and glucosuria, proteinuria,
and glucoproteinuria in women of the polluted areas significantly increased compared with those of the controls with
no urinary findings. Respiratory, renal, and cardiovascular diseases and diabetes in men, and all diseases except
cerebrovascular diseases in women contributed toward an increased mortality of exposed glucoproteinuria groups,
which involved chronic Cd toxicosis with renal tubular dysfunction. In women, the mortality risks for cancer of the
colon and rectum, uterus and kidney and urinary tract were significantly higher in the exposed proteinuria and
glucoproteinuria groups, suggesting associations between renal damage and cancer risk. In exposed women, the
no finding group and glucoproteinuria group also showed increased mortality from ischemic heart diseases,
indicating that all exposed women may be at risk for ischemic heart diseases. Although the control glucosuria
and/or proteinuria group also showed high mortality for diabetes and renal diseases, the increased risk ratio for
renal disease mortality was much higher in exposed subjects with urinary findings, particularly in women.
Conclusions: These findings indicate that inhabitants with renal effects caused by Cd exposure had a poor life
prognosis over long-term observation in both genders. Particularly in women, renal tubular dysfunction indicated
by glucoproteinuria may increase mortality from cancer, ischemic heart diseases, and renal diseases.
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Causes of deaths, particularly cancer mortality in Cd-
exposed areas are an interesting issue. Cd and its
compounds were classified as a human carcinogen by
the International Agency for Research on Cancer [1,2].
Verougstraete et al. reviewed previous studies and re-
ported that longitudinal studies have consistently shown
that workers exposed to Cd are at a higher risk of lung
cancer [3]. In a Belgian cohort study, Nawrot et al.
reported a significant association between lung cancer
risk and Cd exposure from aspiration of house dust
containing Cd caused by past smelter emissions [4].
However, Sorahan et al. investigated mortality for lung
cancer in factory workers exposed to Cd in the United
Kingdom in a follow-up study from 1947 to 2000, but
they detected neither significant increase in the mortal-
ity, nor a positive relationship between Cd exposure and
lung cancer risk [5]. Moreover, in Japanese cohort stud-
ies in the Kakehashi River basin of Ishikawa prefecture,
increased cancer mortality rate has not been reported
except for an increased risk of cancer in women with
renal tubular dysfunction during the early observation
period of Cd-exposed inhabitants [6].
The Jinzu River basin in Toyama is the largest and
highest Cd-polluted area in Japan and endemic for itai-
itai disease, which is clinically characterized by renal
tubular dysfunction caused by an advanced decrease in
renal tubuli [7] and bone pain due to osteomalacia with
Looser zones in roentgenograph of bone [8]. From 1979
to 1984, the Ministry of Environment in Japan con-
ducted health-screening surveys targeting 7348 inhabi-
tants in this polluted area and 2098 control individuals
from several other areas in Toyama [9]. Based on this
health survey, we followed up with these participants in
the Jinzu River basin and control areas for 26 years and
reported increased mortality risks for colorectal cancer,
ischemic heart diseases, and renal diseases in all women
of the Cd-polluted area compared with those in the
control area. However, associations between mortality
and renal tubular dysfunction have not been investigated
in this area. Therefore, in the present study, we analyzed
differences in mortality and causes of deaths in exposed
residents with different urinary findings in the 1979−84
health survey indicating renal tubular dysfunction from
those in the control area after adjusting for age, smoking
status, and hypertension history, which are general risk
factors for cancer and circulatory diseases.
Methods
Study subjects
A total of 7348 participants from a health-screening sur-
vey conducted in 1979–1984 (men, 3363; women, 3985),
which included 97.6% of all inhabitants aged ≥ 50 years,
were targeted in the present follow-up survey. Subjectslived in the Cd-polluted Jinzu River basin that included
one part of Toyama city, all of Fuchu town, all of
Ohsawano town, and one part of Yatsuo town. An
additional 2098 inhabitants aged >50 years (men, 926;
women, 1172) who participated in the health-screening
survey (97.6% participation rate) from non-polluted areas
in two towns and five cities were evaluated as controls in
the present survey.
In the health-screening survey in 1979–1984, urinary
quantitative protein measurement and glucose qualita-
tive tests were performed for all participants from both
the polluted and control areas. According to the urinary
tests, subjects were divided into 4 groups as follows: a
group with neither proteinuria nor glucosuria (no find-
ing group), a group with glucosuria without proteinuria
(glucosuria group), a group with proteinuria without
glucosuria (proteinuria group), and a group with both
glucosuria and proteinuria (glucoproteinuria group), de-
fined with cut-off values of protein ≥ 10 mg/dl and
glucose ≥ +/−. Prevalence of each urinary finding in the
Cd-polluted and control areas are shown in Table 1 that
includes the smoking rate at the examination and history
of hypertension. At this time, information regarding
health status and lifestyle were obtained from the ques-
tionnaire of the health survey in 1979–1984 [9]. Urinary
protein was quantified using the Kingsbury-Clark method,
and qualitative tests using strips were performed to detect
urinary glucose levels.
In the second step of the screening survey, only sub-
jects positive for urinary protein and/or glucose in the
Cd-polluted Jinzu River basin were examined for their
urinary levels of Cd, ß2-micloglobuline (MG), lysozyme
(LTZ) and total amino acids (amino) in the same urine
specimen to confirm that these subjects with urinary
findings have increased Cd and renal tubular dysfunction
indicated by these markers (Table S1 in an Additional
file shows details [see Additional file 1]). These results
suggest that urinary Cd levels in the exposed area were
higher than those in controls; geometrical mean (geo-
metrical standard) = 4.0 (1.9) μg/L for men and 4.4 (2.2)
for women [9], measured by ammonium pyrrolidine
dithiocarbamate (APDC) – methyl isobutyl ketone
(MIBK) extraction atomic absorption spectrometry in
Toyama Institute of Health [10]. The subjects in the
glucoproteinuria group were suspected to have renal
tubular dysfunction because of high positive rates of
urinary low molecular protein, such as ß2-MG and/or
LTZ measured by immunoelectrophoresis and the lyso-
plate method, respectively.
A follow-up survey
Permission was obtained from a regional Legal Affairs
Bureau in June 2005 to use family registry records for
scientific purposes. We collected family registry records
Table 1 Characteristic differences among four groups according to urinary findings in controls and exposed subjects
Pro(−) and Glu(−) Pro(−) and Glu(+) Pro(+) and Glu(−) Pro(+) and Glu(+)
N Rate, % N Rate, % N Rate, % N Rate, %
Men
Controls n = 748 (80.8%) n = 143 (15.4%) n = 27 (2.9%) n = 8 (0.9%)
Smokers 437 58.4 94 65.7 18 66.7 5 62.5
HT history 175 23.4 38 26.6 10 26.6 6 75.0
Exposed subjects n = 2556 (76.8%) n = 498 (14.8%) n = 150 (4.5%) n = 159 (4.7%)
Smokers 1592 62.3 311 62.4 85 56.7 89 60.0
HT history 551 21.6 101 20.3 45 30.0 39 24.5
Women
Controls n = 1039 (88.7%) n = 83 (7.1%) n = 44 (3.8%) n = 6 (0.5%)
Smokers 26 2.5 1 1.2 1 2.3 0 0.0
HT history 254 24.4 24 28.9 17 38.6 1 16.6
Exposed subjects n = 3184 (79.9%) n = 398 (10.0%) n = 136 (3.4%) n = 267 (6.7%)
Smokers 257 82.4 23 7.4 7 2.2 25 8.0
HT history 650 76.7 98 11.6 41 4.8 58 6.8
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
n: number of all subjects in each group, N: number of subjects, (%): rate per total.
Maruzeni et al. Environmental Health 2014, 13:18 Page 3 of 12
http://www.ehjournal.net/content/13/1/18of all subjects from each city office and determined their
survival status (alive or dead) as of November 30, 2005
and the date of death if applicable. The address at the
time of the health survey was considered as the family
registry address. Cause of death was determined from
vital statistics data by linking it to health survey data
with survival status based on birthday, death day, gender,
and address after obtaining permission from the Ministry
of Health, Labour and Welfare to use vital statistics for
other research purposes on August 12, 2009.
The Ethics Committee of Kanazawa Medical University
in Uchinada, Ishikawa 920–0293, Japan, where the analysis
of the data was conducted, approved the present study.
According the follow-up survey, following results were
obtained; a total of 166 subjects (1.7%; 133 exposed and
33 controls) were lost to follow-up during the observation
period because their status could not be determined. In all
areas, 5351 deaths occurred. The cause of death was de-
termined for 5276 cases (98.5%) by successful data linkage
and classified according to the 9th Revised International
Classification of Diseases (ICD 9) from 1979 to 1994 and
the ICD 10 from 1995 to 2005 (Table S2 in an Additional
file shows more details [see Additional file 1]).
Mortality analysis
To determine the survival period of each subject, the
health survey date was used as the starting point and the
life status survey date, November 30, 2005, was consid-
ered the end of follow-up for living subjects. A total of
232 subjects, including 157 cases with unknown life
status and 75 cases with unknown causes of death were
excluded from the analysis. Mortalities of all subjects inthe polluted area and controls were calculated by the
person-years method for all 26 years from baseline in
1979 to November 30, 2005.
For standardized mortality analysis for all causes,
standardized mortality ratio (SMR) was calculated after
adjusting age using age distribution and death rates per
decade of the general Japanese population during the
observation period as a standard population. Subse-
quently, analysis of the risk of mortality after adjustment
for age, smoking status at present (yes: 1, no: 0), and his-
tory of hypertension (yes: 1, no: 0) was conducted using
Cox’s proportional hazard model in each gender to com-
pare 5 groups of 4 exposed groups with different urinary
findings and 1 control group with urinary protein posi-
tive and/or glucose positive findings, with the control no
finding group. At this time, controls in the glucosuria
group, proteinuria group, glucoproteinuria group were
set into one group (with findings) because of a small
number of subjects for mortality analysis. All analyses
were performed using SPSS 16.0 software (SPSS Inc.,
Chicago, IL, USA). P values of <0.05 were considered
statistically significant.
Results
Table 2 shows the SMRs and hazard ratios (mortality
risk ratios) in the groups of both genders with different
urinary findings in the control and Cd-polluted areas.
There is a generally higher mortality in the Cd polluted
area compared with the control area. In men, the SMRs
of the control group with urinary findings and the
exposed glucoproteinuria group in the Cd-exposed area
were significantly higher than that in the general
Table 2 The standardized mortality ratios and hazard ratios in different groups in controls and exposed subjects
Area Urinary findings Groups N PY PY/person D SMR (95% CI) Hazard ratio (95% CI)
Men
Control Pro(−) and Glu(−) No finding 748 12514 16.7 441 0.88 (0.80, 0.96) 1.00
Pro(+) and/or Glu(+) With findings 178 2608 14.7 118 1.24 (1.01, 1.46) 1.39 (1.13, 1.70)**
Exposed Pro(−) and Glu(−) No finding 2556 44636 17.5 1595 0.90 (0.85, 0.94) 1.02 (0.92, 1.14)
Pro(−) and Glu(+) Glucoseuria 498 8444 17.0 331 0.96 (0.86, 1.07) 1.10 (0.95, 1.27)
Pro(+) and Glu(−) Proteinuria 150 1905 12.7 123 1.19 (0.98, 1.40) 1.27 (1.03, 1.57)*
Pro(+) and Glu(+) Glucoproteinuria 159 1579 9.9 147 1.40 (1.17, 1.63) 1.57 (1.29, 1.90)***
Women
Control Pro(−) and Glu(−) No finding 1039 19085 18.4 455 0.89 (0.81, 0.97) 1.00
Pro(+) and/or Glu(+) with findings 133 1884 14.2 77 1.16 (0.90, 1.41) 1.26 (0.99, 1.61)
Exposed Pro(−) and Glu(−) No finding 3184 64520 20.3 1405 0.84 (0.90, 0.88) 0.93 (0.83, 1.03)
Pro(−) and Glu(+) Glucoseuria 398 6568 16.5 278 1.27 (1.12, 1.41) 1.40 (1.20, 1.63)***
Pro(+) and Glu(−) Proteinuria 136 1947 14.3 106 1.44 (1.16, 1.71) 1.77 (1.42, 2.20)***
Pro(+) and Glu(+) Glucoproteinuria 267 2406 9.0 257 2.02 (1.77, 2.26) 2.40 (2.16, 2.80)***
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
N number of subjects, PY person year, D number of death, SMR standardized mortality ratio.
CI confidence interval, hazard ratio adjusted with age, smoking status, and history of hypertension.
*P < 0.05, **P < 0.01, ***P < 0.001 compared with Pro(−) and Glu(−) in controls.
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ing groups were significantly lower in both the exposed
and control areas. The mortality risk ratios for all causes
in the proteinuria and glucoproteinuria groups of ex-
posed men were 1.27 and 1.57, respectively, and signifi-
cantly increased compared with the no finding group in
the control area. Similarly, the mortality risk ratio of the
control group with urinary findings was also significantly
increased compared with the no finding group in the
controls.
In women, the SMRs were significantly higher in the
exposed glucosuria, proteinuria, and glucoproteinuria
groups compared with the general Japanese population,
but not in the control group with urinary findings
(Table 2). The mortality risk ratios for all causes in these
three exposed groups, glucosuria, proteinuria, and gluco-
proteinuria groups, were 1.40, 1.77, and 2.40, respect-
ively, and were significantly increased compared with
the control no finding group, whereas increased mortal-
ity risk ratio was not significant in the control group
with urinary findings (Table 2).
The number of deaths and mortality risk ratios for
specific causes of deaths in the four exposed groups and
one control group with urinary findings in men com-
pared with the control no finding group are shown in
Tables 3 and 4. In men, no significant increased mortal-
ity risk ratio for malignant neoplasms were found in any
exposed and control groups. The mortality risk ratios for
endocrine, nutritional and metabolic diseases in the ex-
posed glucosuria group and the glucoproteinuria group
in the exposed areas and control group with urinaryfindings were 3.42, 5.80, and 6.80, respectively, and were
significantly increased compared with the control no
finding group. At this time, all deaths from endocrine,
nutritional, and metabolic diseases in these groups
except the control no finding group were from diabetes
(Table 3).
Regarding cardiovascular diseases in men, the mortal-
ity risk ratio for ischemic heart disease was significantly
increased in the glucosuria and glucoproteinuria groups,
and the risk for heart failure was higher in the exposed
proteinuria group (Table 4). Diseases of the respiratory
systems showed increased mortality risk only in the male
exposed glucoproteinuria group. Particularly, the mortal-
ity risk ratio for renal diseases, a main disease at the
subcategory of kidney and urinary tract diseases, of the
exposed glucoproteinuria group was 12.4 in men and
a very high value. Similarly, renal diseases also showed a
high mortality risk ratio in the male exposed proteinuria
group. In the male exposed glucoproteinuria group, the
mortality risk ratio for external causes, particularly by
accident, was significantly increased compared with the
male control no finding group because the five deaths
from toxic effects of Cd included deaths by accident
(Table 4). In contrast, the mortality risk ratio for external
causes in the male exposed no finding group was signifi-
cantly lower compared with the control no finding group.
Tables 5 and 6 also show hazard ratios for specific
causes of four exposed groups and one control group
with urinary findings compared with the control no
finding group in women. The mortality risk ratios for
all malignant neoplasms in the female exposed proteinuria
Table 3 Hazard ratios for cancer and diabetes in the groups with different urinary findings in men
Cause of deaths Control areas Cd polluted areas
Pro(−) and Glu(−) Pro(+) and/or Glu(+) Pro(−) and Glu(−) Pro(−) and Glu(+) Pro(+) and Glu(−) Pro(+) and Glu(+)
(N=748) (N=178) (N=2556) (N=331) (N=123) (N=147)
D HR D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI)
Malignant neoplasms 142 1.00 32 1.16 (0.79, 1.71) 522 1.05 (0.87, 1.27) 82 0.87 (0.66, 1.14) 26 0.97 (0.62, 1.51) 23 1.04 (0.66, 1.63)
Esophagus 2 1.00 2 4.58 (0.64, 32.6) 20 2.63 (0.61, 11.3) 6 3.59 (0.70, 18.5) 1 2.94 (0.26, 32.8) 0 - -
Stomach 48 1.00 9 1.02 (0.50, 2.09) 142 0.88 (0.63, 1.25) 26 0.87 (0.53, 1.42) 6 0.66 (0.26, 1.68) 6 0.80 (0.34, 1.90)
Colon, rectum 14 1.00 2 0.68 (0.15, 2.98) 53 1.01 (0.55, 1.82) 7 0.73 (0.29, 1.80) 2 0.85 (0.19, 3.78) 2 0.99 (0.22, 4.41)
Liver 15 1.00 1 0.35 (0.05, 2.64) 42 0.82 (0.44, 1.51) 8 0.84 (0.35, 2.01) 5 2.27 (0.81, 6.36) 3 1.59 (0.45, 5.61)
Gall bladder 6 1.00 1 0.93 (0.11, 7.70) 21 1.02 (0.41, 2.55) 4 1.01 (0.29, 3.60) 0 - - 0 - -
Pancreas 7 1.00 2 1.76 (0.35, 8.71) 33 1.45 (0.60, 3.48) 6 1.40 (0.45, 4.35) 0 - - 2 2.16 (0.42, 11.0)
Lung 30 1.00 7 1.13 (0.50, 2.57) 121 1.08 (0.72, 1.62) 11 0.52 (0.26, 1.03) 5 0.84 (0.32, 2.18) 6 1.19 (0.49, 2.89)
Prostate 3 1.00 2 3.81 (0.63, 22.9) 13 1.16 (0.33, 4.09) 5 2.32 (0.55, 9.74) 3 1.43 (0.15, 14.2) 0 - -
Bladder 3 1.00 0 - - 11 1.03 (0.28, 3.72) 1 0.48 (0.05, 4.58) 1 1.87 (0.19, 18.3) 0 - -
Kidney and urinal tract 1 1.00 1 5.00 (0.31, 80.4) 5 1.23 (0.14, 11.1) 0 - - 2 11.0 (0.96, 125) 1 4.39 (0.25, 76.9)
Lymph, blood forming organs 6 1.00 0 - - 24 1.13 (0.46, 2.78) 4 0.97 (0.27, 3.45) 1 1.05 (0.13, 8.82) 2 2.27 (0.44, 11.6)
Endocrine, nutritional and metabolic diseases 4 1.00 5 6.81 (1.82, 25.5)** 15 0.89 (0.29, 2.71) 11 3.42 (1.08, 10.8)* 0 - - 4 5.80 (1.39, 24.2)*
Diabetes 1 1.00 5 27.8 (3.23, 238)** 11 2.56 (0.33, 20.0) 11 13.4 (1.72, 105)* 0 - - 4 23.3 (2.53, 214)**
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
N number of subjects, D number of deaths, HR Hazard ratio, CI confident interval.















Table 4 Hazard ratios for the other diseases in the groups with different urinary findings in men
Cause of deaths
Control areas Cd polluted areas
Pro(−) and Glu(−) Pro(+) or/and Glu(+) Pro(−) and Glu(−) Pro(−) and Glu(+) Pro(+) and Glu(−) Pro(+) and Glu(+)
(N=748) (N=178) (N=2556) (N=331) (N=123) (N=147)
D HR D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI)
Cardiovascular diseases 61 1.00 20 1.61 (0.96, 2.69) 255 1.20 (0.91, 1.60) 51 1.18 (0.81, 1.73) 23 1.55 (0.95, 2.52) 31 1.81 (1.16, 2.85)*
Ischemic Heart diseases 20 1.00 7 1.77 (0.75, 4.19) 112 1.65 (1.02, 2.66)* 16 1.12 (0.57, 2.19) 5 1.02 (0.38, 2.07) 14 2.76 (1.35, 5.67)**
Heart failure 28 1.00 11 1.84 (0.89, 3.81) 98 1.00 (0.65, 1.54) 28 1.46 (0.85, 2.49) 14 2.00 (1.04, 3.86)* 16 1.67 (0.87, 3.20)
Cerebrovascular diseases 68 1.00 16 1.23 (0.71, 2.13) 207 0.90 (0.68, 1.19) 53 1.14 (0.79, 1.66) 21 1.19 (0.71, 1.99) 16 0.94 (0.54, 1.65)
Cerebral hemorrage 20 1.00 4 1.05 (0.36, 3.11) 33 0.48 (0.27, 0.87)* 11 0.91 (0.43, 1.92) 8 2.31 (0.99, 5.38) 0 - -
Cerebral infarction 41 1.00 11 1.47 (0.75, 2.87) 130 0.94 (0.65, 1.34) 36 1.28 (0.81, 2.03) 6 0.49 (0.19, 1.24) 12 1.22 (0.63, 2.37)
Subarachnoid hemorrhage 4 1.00 0 - - 11 0.68 (0.22, 2.17) 2 0.32 (0.04, 2.88) 2 2.74 (0.49, 15.3) 0 - -
Diseases of the respiratory systems 77 1.00 22 1.53 (0.94, 2.48) 301 1.11 (0.86, 1.43) 63 1.22 (0.87, 1.71) 27 1.44 (0.92, 2.27) 30 1.64 (1.06, 2.54)*
Diseases of the digestive systems 14 1.00 3 1.17 (0.33, 4.12) 55 1.19 (0.65, 2.19) 17 1.84 (0.88, 3.83) 3 1.13 (0.32, 4.00) 7 2.38 (0.93, 6.13)
Kidney and urinal tract diseases 5 1.00 3 3.15 (0.75, 13.2) 28 1.51 (0.58, 3.94) 5 1.47 (0.43, 5.10) 6 5.60 (1.68, 18.7)** 11 9.51 (3.14, 28.8)***
Renal diseases 4 1.00 3 3.91 (0.87, 17.5) 23 1.59 (0.54, 4.62) 5 1.85 (0.50, 6.90) 6 7.01 (1.94, 25.3)** 10 12.4 (3.77, 41.1)***
External causes of mortality 39 1.00 9 1.22 (0.59, 2.52) 85 0.58 (0.39, 0.85)** 12 0.58 (0.32, 1.06) 3 0.46 (0.14, 1.48) 13 2.32 (1.23, 4.38)*
Accident 29 1.00 5 0.91 (0.35, 2.35) 68 0.60 (0.39, 0.95)* 12 0.61 (0.31, 1.20) 3 0.57 (0.17, 1.88) 13 2.69 (1.36, 5.34)**
Accident except Cd toxicity 29 1.00 5 0.91 (0.35, 2.36) 68 0.60 (0.39, 0.95)* 12 0.61 (0.31, 1.21) 3 0.59 (0.18, 1.94) 8 1.76 (0.78, 3.94)
Toxic effects of cadmium 0 1.00 0 - - 0 - - 0 - - 0 - - 5 - -
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
N number of subjects, D number of deaths, HR Hazard ratio, CI confident interval, Cd toxicity = Toxic effect of cadmium.















Table 5 Hazard ratios for cancer and diabetes in the groups with different urinary findings in women
Cause of deaths Control areas Polluted areas
Pro(−) and Glu(−) Pro(+) or/and Glu(+) Pro(−) and Glu(−) Pro(−) and Glu(+) Pro(+) and Glu(−) Pro(+) and Glu(+)
(N=1039) (N=133) (N=3184) (N=398) (N=136) (N=267)
D HR D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI)
Malignant neoplasm 97 1.00 17 1.57 (0.94, 2.64) 339 1.03 (0.82, 1.31) 51 1.34 (0.95, 1.90) 21 1.97 (1.21, 3.19)** 26 1.64 (1.05, 2.56)*
Esophagus 0 1.00 0 - - 2 - - 2 - - 0 - - 0 - -
Stomach 26 1.00 7 2.29 (0.99, 5.34) 77 0.99 (0.62, 1.58) 11 1.12 (0.55, 2.30) 5 1.42 (0.49, 4.09) 5 0.94 (0.35, 2.51)
Colon, rectum 7 1.00 1 1.14 (0.14, 9.33) 55 2.42 (1.10, 5.34)* 5 1.77 (0.56, 5.59) 0 - - 6 4.27 (1.39, 13.1)*
Liver 5 1.00 0 - - 4 .54 (0.52, 4.54) 2 0.70 (0.08, 6.27) 1 2.59 (0.29, 23.3) 0 - -
Gall bladder 7 1.00 1 1.28 (0.16, 10.4) 36 1.44 (0.63, 3.28) 8 3.21 (1.16, 8.90)* 1 1.40 (0.17, 11.4) 1 1.09 (0.13, 9.09)
Pancreas 12 1.00 2 1.60 (0.35, 7.24) 25 0.60 (0.29, 1.24) 4 0.89 (0.28, 2.82) 3 2.39 (0.66, 8.62) 2 1.03 (0.22, 4.85)
Lung 17 1.00 2 1.03 (0.24, 4.50) 35 0.50 (0.28, 0.92)* 4 0.56 (0.19, 1.67) 2 1.01 (0.23, 4.38) 3 1.04 (0.29, 3.67)
Breast 4 1.00 0 - - 11 0.76 (0.24, 2.44) 1 0.80 (0.09, 7.19) 2 5.73 (1.04, 31.4)* 0
Uterus 5 1.00 1 4.56 (0.41, 50.6) 10 1.15 (0.24, 5.57) 0 2 10.5 (1.46, 75.1)* 3 10.8 (1.62, 71.7)*
Ovary 5 1.00 0 - - 7 1.17 (0.24, 5.67) 2 2.73 (0.38, 19.6) 0 - - 0
Bladder 1 1.00 1 6.72 (0.40, 112) 4 1.21 (0.13, 11.2) 0 - - 0 - - 0 - -
Kidney and urinal tract 1 1.00 0 - - 3 0.82 (0.08, 8.06) 1 2.61 (0.16, 42.1) 2 19.4 (1.73, 217)* 2 15.5 (1.25, 192)*
Lymph, blood forming organs 4 1.00 1 2.46 (0.27, 22.0) 20 1.38 (0.46, 4.08) 3 2.10 (0.47, 9.46) 2 5.11 (0.93, 28.1) 2 4.56 (0.79, 26.1)
Endocrine, nutritional and metabolic diseases 3 1.00 1 2.61 (0.27, 25.2) 14 1.37 (0.39, 4.84) 11 8.58 (2.38, 30.9)*** 1 2.70 (0.28, 26.1) 4 6.67 (1.44, 31.0)*
Diabetes 2 1.00 1 4.11 (0.37, 45.6) 6 0.81 (0.16, 4.09) 11 12.7 (2.80, 57.8)*** 1 4.21 (0.38, 46.8) 4 10.0 (1.73, 57.8)**
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
N number of subjects, D number of deaths, HR Hazard ratio, CI confident interval.















Table 6 Hazard ratios for the other diseases in the groups with different urinary findings in women
Cause of deaths Control areas Cd polluted areas
Pro(−) and Glu(−) Pro(+) or/and Glu(+) Pro(−) and Glu(−) Pro(−) and Glu(+) Pro(+) and Glu(−) Pro(+) and Glu(+)
(N=1039) (N=133) (N=3184) (N=398) (N=136) (N=267)
D HR D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI) D HR (95% CI)
Cardiovascular diseases 90 1.00 13 0.98 (0.55, 1.77) 271 0.95 (0.74, 1.22) 54 1.36 (0.96, 1.92) 20 1.48 (0.89, 2.46) 52 2.02 (1.40, 2.91)***
Ischemic Heart diseases 23 1.00 4 1.49 (0.51, 4.37) 127 1.64 (1.01, 2.66)* 21 2.32 (1.25, 4.33)** 5 1.53 (0.52, 4.49) 9 3.79 (1.95, 7.39)***
Heart failure 47 1.00 6 0.75 (0.32, 1.77) 111 0.77 (0.54, 1.10) 27 1.23 (0.76, 1.99) 10 1.30 (0.63, 2.67) 27 1.71 (1.03, 2.83)*
Cerebrovascular diseases 89 1.00 20 1.50 (0.92, 2.44) 236 0.88 (0.68, 1.13) 43 1.09 (0.75, 1.58) 21 1.70 (1.04, 2.77)* 29 1.21 (0.78, 1.87)
Cerebral hemorrage 19 1.00 4 1.64 (0.56, 4.86) 45 0.70 (0.41, 1.22) 3 0.38 (0.11, 1.30) 4 1.70 (0.58, 5.02) 4 0.77 (0.22, 2.68)
Cerebral infarction 54 1.00 14 1.75 (0.97, 3.17) 142 0.92 (0.66, 1.27) 28 1.16 (0.73, 1.86) 9 1.31 (0.65, 2.67) 14 1.09 (0.60, 1.99)
Subarachnoid hemorrhage 7 1.00 1 1.16 (0.14, 9.43) 20 0.95 (0.40, 2.27) 3 1.15 (0.30, 4.47) 3 3.94 (1.01, 15.4)* 1 0.75 (0.09, 6.33)
Diseases of the respiratory systems 64 1.00 4 0.43 (0.16, 1.19) 205 1.01 (0.75, 1.36) 35 1.23 (0.80, 1.88) 11 1.22 (0.62, 2.38) 27 1.75 (1.10, 2.78)*
Diseases of the digestive systems 16 1.00 2 0.93 (0.21, 4.10) 53 1.02 (0.57, 1.84) 18 2.64 (1.32, 5.29)** 4 2.12 (0.70, 6.39) 11 2.96 (1.33, 6.60)**
Kidney and urinal tract diseases 8 1.00 5 4.06 (1.22, 13.5)* 38 1.35 (0.63, 2.91) 20 5.86 (2.57, 13.3)*** 8 7.10 (2.57, 19.6)*** 30 20.1 (8.99, 44.8)***
Renal diseases 7 1.00 5 4.78 (1.39, 16.4)* 32 1.33 (0.59, 3.03) 17 5.73 (2.37, 13.9)*** 8 8.31 (2.91, 23.7)*** 29 23.2 (9.92, 54.3)***
External causes of mortality 35 1.00 2 0.47 (0.11, 1.95) 75 0.60 (0.40, 0.91)* 10 0.91 (0.48, 1.73) 5 (0.62, 3.53) 49 7.01 (4.41, 11.1)***
Accident 21 1.00 1 0.40 (0.05, 2.97) 56 0.75 (0.45, 1.25) 10 1.17 (0.55, 2.49) 5 2.07 (0.78, 5.51) 49 12.3 (7.16, 21.2)***
Accident except Cd toxicity 21 1.00 1 0.44 (0.06, 3.28) 55 0.70 (0.42, 1.17) 5 0.60 (0.23, 1.59) 5 2.16 (0.81, 17.3) 4 1.28 (0.43, 3.84)
Toxic effects of cadmium 0 1.00 0 - - 1 - - 5 - - 0 - - 45 - -
Pro(+): urinary protein ≥ 10 mg/dL, Pro(−): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/−, Glu(−): urinary glucose negative.
N number of subjects, D number of deaths, HR Hazard ratio, CI confident interval, Cd toxicity = Toxic effect of cadmium.
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http://www.ehjournal.net/content/13/1/18and glucoproteinuria groups were 1.97 and 1.64, respect-
ively, and significantly increased compared with the con-
trol no finding group (Table 5). Colorectal cancer, uterine
cancer, and kidney and urinary tract cancer in the exposed
glucoproteinuria group, and breast cancer, uterine cancer,
and kidney and urinary tract cancer in the exposed pro-
teinuria group showed a significant increase of mortality
risk ratios in women. Increased mortality risk ratios for
gall bladder cancer in the exposed glucosuria group and
for colorectal cancer in the exposed no finding group were
found in women (Table 5). Mortality risk ratios for
diabetes were significantly increased in the exposed gluco-
suria and glucoproteinuria groups in women (Table 5).
In women, the exposed glucoproteinuria group showed
significantly increased mortality risk ratios for cardiovas-
cular diseases, especially ischemic heart disease, diseases
of the respiratory system, diseases of the digestive system,
renal diseases, and external causes of deaths including
accidents (Table 6). Mortality risk ratios for cerebrovascu-
lar diseases and renal diseases of the exposed proteinuria
group and for ischemic heart diseases, digestive diseases
and renal diseases of the exposed glucosuria group were
significantly increased in women (Table 6). The mortality
risk ratio for ischemic heart diseases was also significantly
increased in the exposed no finding group in women. In
addition, the mortality risk ratio for renal diseases was
significantly increased in the control group with urinary
findings as well as the exposed groups with urinary
findings in women (Table 6).Discussion
Causes of deaths and renal tubular dysfunction
In the present study, mortality risks of the exposed glu-
coproteinuria groups suspected of renal tubular dysfunc-
tion due to increased urinary β2-MG and/or LTZ were
significantly increased in both genders. In the dead
subjects of glucoproteinuria group, 5 men (3.4%) and 45
women (17.5%) died from toxic effects of cadmium (Cd
toxicosis), which were classified into accidents. Causes
of deaths contributed to their increased mortality other
than Cd toxicosis were respiratory diseases, renal dis-
eases, cardiovascular diseases, and diabetes in men, and
all diseases except cerebrovascular diseases in women.
In the Cd-exposed residents in the Jinzu River basin, the
prevalence of subjects with glucoproteinuria was 4.7% in
men and 6.7% in women and much higher than that in
controls (0.9% in men, and 0.5% in women), suggesting
that environmental Cd exposure increased the number
of renal tubular dysfunction cases indicated by glucopro-
teinuria and characterized by an unfavorable long-term
life prognosis. Particularly in women, health effects
caused by Cd exposure cover almost all diseases to
shorten the life span.Although the prevalence of the exposed glucosuria
and proteinuria groups were similar to those of the
glucosuria and proteinuria groups in controls in both
genders, mortality risks of these exposed groups, par-
ticularly the proteinuria group, were higher than that in
the control group with urinary findings in women. Re-
garding the causes of deaths, mortality risks for malig-
nant neoplasms and cerebrovascular diseases of the
exposed proteinuria group were increased, whereas the
increased risks of the control group with urinary find-
ings were not significant in women. These results sug-
gest that the effect of Cd exposure on mortality was
exhibited in women with only proteinuria who might
include renal tubular dysfunction cases because 40% of
them showed low molecular proteinuria at the second
screening tests at baseline.
Toxic effects of Cd (Cd toxicosis and itai-itai diseases) and
renal diseases
The mortality risk ratios for accidents including the
toxic effects of Cd were high, but they were not high for
accidents without Cd toxic effects in the glucoproteinuria
groups in both genders, suggesting that Cd toxicosis and
itai-itai disease significantly increased the mortality of
residents with renal tubular dysfunction. Itai-itai disease
involves suffering from bone pain and renal tubular dys-
functions, and renal damage is pathologically character-
ized by renal atrophy due to an advanced decrease in
renal tubuli [7], which leads to renal failure after long-
term observation [11]. Therefore, mortality risk for renal
diseases in the glucoproteinuria groups might be underes-
timated because they were diagnosed as itai-itai disease,
not renal diseases even if they had renal failure. Consist-
ently, in the first 10 years observation, the numerous
deaths due to itai-itai diseases were observed in all pol-
luted subjects without increased mortality from renal dis-
eases (Table S1 in an Additional file shows this in more
detail [see Additional file 2]).
Since Lauwers and De Wals in Belgium suggested that
increased mortality rates from renal disease were caused
by environmental Cd exposure, renal diseases have been
an important cause of death among inhabitants living in
Cd-polluted areas [12]. In the Cd-polluted Kakehashi River
basin in Japan, we have reported higher mortality risks for
renal diseases among subjects with β2-MG ≥1000 μg/g Cr
in both sexes [6,13] and urinary Cd ≥10 μg/g Cr in women
[14,15]. In the present study, significantly increased mor-
tality risks for kidney and urinary tract diseases, particu-
larly renal diseases including renal failure, were observed
in the exposed two groups with proteinuria group in men,
and in the three exposed groups with glucosuria and/or
proteinuria in women. Similarly, renal disease risk of the
control group with urinary findings was significantly in-
creased in women, suggesting that women with glucosuria
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fatal renal diseases. However, the mortality risk ratio for
renal diseases in the exposed glucoproteinuria group was
3-fold higher in men and 5-fold higher in women, suggest-
ing that renal dysfunction induced by Cd may enhance
deterioration of renal function in these groups.
Cancer mortality
Mortality because of cancer is a focal research concern
because Cd and its compounds were classified as a human
carcinogen by the International Agency for Research on
Cancer [1,2]. Several follow-up surveys in factory workers
have been conducted [5,16-18], and results suggest that
mortality increases because of renal diseases and malig-
nant neoplasms, such as lung cancer and prostate cancer.
In a study of inhabitants exposed to environmental Cd in
Belgium, an increased risk of lung cancer was reported in
those living in high exposure areas compared with less
polluted areas [4]. However, in the present study, the risk
of mortality for lung cancer in the exposed subjects was
not higher in men and was even significantly lower in
women. The Cd exposure route of the factory workers
and inhabitants of the Belgian polluted area was different
from our subjects in Japan. Aspiration of dust in workers
and Belgian inhabitants and oral intake in Japanese inhabi-
tants may be the cause of inconsistencies in the results for
lung cancer risk. An increased mortality risk for prostatic
cancer was also not found in the present study.
In our study, increased colorectal cancer mortality risk
was observed in women with glucoproteinuria in ex-
posed areas. This is a new finding that has never been
reported in any previous epidemiologic studies for fac-
tory workers and residents in Cd-polluted areas. How-
ever, mortality risk for colorectal cancer also increased
in women without urinary findings in the polluted area,
indicating an association of colorectal cancer mortality
with Cd exposure, not renal tubular dysfunction. In fact,
mortality risk for colorectal cancer significantly increased
in all female exposed subjects compared with all controls
in the present study, and we have reported this evidence
in our previous study report (Table S2 in an Additional file
shows this in more detail [see Additional file 2]). Recently,
an inverse association between 25-hydroxy (OH)-vitamin
D (Vit. D) and colorectal cancer was identified in a large-
scale epidemiologic study of a western European popula-
tion [19]. Feskanich et al. also reported that women in the
highest quintile of 1,25-(OH)2-Vit. D had a higher risk for
colorectal cancer [20]. In the Jinzu River basin, Aoshima
et al. investigated serum 25-OH-Vit. D and 1,25-(OH)2-
Vit. D levels in inhabitants with relatively maintained
glomerular function and found that only 1,25-(OH)2-Vit.
D levels were higher than the upper range of the reference
value because of compensatory secretion of parathyroid
hormone, particularly in women [21]. These effects of Cdexposure on 1,25-(OH)2-Vit. D may increase the risk of
colorectal cancer in women living in the Jinzu River
basin. However, a further study is necessary to clarify
the mechanisms of association between colorectal cancer
and Cd exposure.
In the exposed proteinuria group and glucoproteinuria
group in women, mortality risks for kidney and urinary
tract cancer were significantly increased in women. Mor-
tality risk ratios for this cancer were also high in men
(11.0, proteinuria group; 4.39, glucoproteinuria group),
although their increases were not statistically significant.
Ilyasova and Schwartz performed a systemic review of
the literature on cadmium and renal cancer and reported
that exposure to cadmium appears to be associated with
renal cancer [22]. These results suggest that renal dam-
age induced by Cd may be a risk for kidney and urinary
tract cancer.
Mortality risks for uterine cancer in the exposed pro-
teinuria group and glucoproteinuria group and for breast
cancer in the exposed proteinuria group were higher in
women, albeit the numbers of deaths were small. Re-
garding uterine cancer, Akesson et al. reported that
dietary Cd intake increased postmenopausal endometrial
cancer incidence in a Swedish cohort [23], suggesting
estrogen-mimicking effects of Cd exposure in women.
For breast cancer, Nishijo et al. reported an increased
mortality risk of breast cancer in women with urinary
β2-MG ≥1000 μg/g Cr during the first 5 and 10 years of
observation of Cd-exposed inhabitants in the Kakehashi
River basin, Japan [6]. In the U.S. population, McElroy
et al. reported increased breast cancer risk with increas-
ing urinary Cd levels based on a case–control study [24].
Julin et al. performed a cohort study of the Swedish
population and found associations between dietary Cd
and breast cancer incidence [25]. Collectively, these
study results suggest that Cd exposure increases the
risks of hormone-related cancers, particularly in women.
Circulatory diseases, respiratory diseases and digestive
diseases
In the present study, significant increased mortality risk
for ischemic cardiovascular diseases was observed in the
exposed glucoproteinuria group and no finding group in
men and in the three exposed groups other than the
proteinuria group in women. Previously, we have re-
ported that the risk of mortality for ischemic heart dis-
eases was significantly higher in all women living in the
polluted areas than that in controls (Table S2 in an
Additional file shows this in more detail [see Additional
file 2]), and in the present study, we found that mortality
risk ratios for this disease were higher particularly in the
exposed glucoproteinuria group in both sexes (2.76,
men; 3.79, women). In addition, we focused on the
subjects who didn’t smoke and had no diabetes, and
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(Table S3 and S4 in an Additional file show more details
[see Additional file 1]), because statistical adjustment of
effects of smoking status on mortality might be not suffi-
cient and diabetes might influence mortality rather than
direct Cd exposure. However, even after excluding the
diabetes and smokers, significant increased mortality risk
ratios from ischemic heart diseases were exhibited in
both genders. In the U.S. population, Menke et al. found
that urinary Cd was associated with an increased risk of
cardiovascular mortality, particularly coronary vascular
diseases, in men who participated in the 1988–1991
United States National Health and Nutrition Examin-
ation Survey (NHANES) [26], and Tellez-Plaza et al. also
reported an association of Cd exposure and cardiovascu-
lar mortality in both men and women who were partici-
pants in the 1999–2004 NHANES survey [27]. These
results are concordant with our results, albeit their expos-
ure level was at background. In Shipham, a Cd-polluted
area in the United Kingdom, Elliott et al. reported a higher
standardized mortality ratio for hypertension and cere-
brovascular disease of borderline significance but no
significant excess mortality from cerebrovascular dis-
ease in their geographical study [28].
In the exposed glucoproteinuria group, mortality risks
for respiratory diseases increased in both genders. In the
non-smokers, hazard risk ratios for respiratory diseases
were also significantly increased in glucoproteinuria groups
of both genders (Additional file 1: Table S3 and S4). More-
over, in the exposed glucoproteinuria group, deaths from
acute bronchitis and pneumonia were 75% in men and
90% in women of deaths from respiratory diseases
(60% in men and 70% in women in controls), suggest-
ing increasing deaths from respiratory inflammation.
Taken together, increased mortality for respiratory
diseases may be caused from poor health status to get
fatal inflammation due to renal dysfunction induced
by Cd exposure, not due to smoking.
In women, mortality risks for digestive diseases for
digestive diseases were higher in the exposed glucosuria
group and glucoproteinuria group. In the glucoprotei-
nuria group, the rate of deaths for gastrointestinal dis-
eases was 65% of deaths for all digestive diseases, but
30% in the glucosuria group and 35% in the control no
finding group. These results suggest that renal tubular
dysfunction induced by Cd might increase body stress and
increase gastrointestinal diseases such as peptic ulcer.
Conclusion
Our findings indicate that the life prognosis of residents
with renal dysfunction induced by Cd exposure was poor
in the Jinzu River basin, Toyama, Japan, and diabetes,
cardiovascular disease, particularly ischemic heart dis-
eases, pneumonia and bronchitis, and renal diseasescontributed to increasing mortality in both genders.
Increased mortality risks for malignant neoplasms and
digestive diseases were also evident in women with Cd
nephropathy indicated by glucoproteinuria.
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